Sign Up Today and Learn More About Intocell Stock
Invest in or calculate the value of your shares in Intocell or other pre-IPO companies through EquityZen's platform.
![Intocell](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/intocell_logo-d3ed32c94db9760f.png)
Intocell Stock
Intocell is a biotechnology company that develops antibody drug conjugate (ADC) platform technologies.
About Intocell Stock
Founded
2015
Industries
Software, Data and Analytics, Artificial Intelligence
Intocell Press Mentions
Stay in the know about the latest news on Intocell
Asia CDMO giants Wuxi and Samsung to grow production ...
bioworld • Jan 29, 2024
ADC deals keep rolling as GSK and Dong-A ST cut new ...
bioworld • Jan 29, 2024
WuXi CRDMO spinoff WuXi XDC inks partnership with IntoCell
fiercebiotech • Jan 05, 2024
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development
prnewswire • Jan 03, 2024
Samsung Bioepis, Intocell to co-develop ADC drugs
koreabiomed • Dec 24, 2023
Intocell Management
Leadership team at Intocell
Managing Director & CFO
Seo Young-seok
Advisor - Global Business Development
Dana Zhang
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Intocell current valuation
- Intocell stock price
- Available deals in Intocell and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Intocell stock?
Accredited investors can buy pre-IPO stock in companies like Intocell through EquityZen funds. These investments are made available by existing Intocell shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Intocell stock?
Shareholders can sell their Intocell stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."